
GSK vs IMMX
$GSK vs $IMMX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs IMMX: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+5.7%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only IMMX beat the market over the past year, by 67.4%, while GSK trailed the S&P 500 at +5.7% by 2.1%.
- ·The last month has flipped the order: GSK has held up better over the month (-6.7% against -16.6%) even though IMMX leads over the year.
- ·IMMX has support 23.9% below at $5.29; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs IMMX: the quick read
- ·GSK is the larger company by market cap ($96.73B vs $590M).
- ·IMMX has been more active on our scanner (153 vs 80 alerts in 30 days).
- ·IMMX has the smaller float (83.8M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·IMMX trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 153 and 80 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 164x the market cap of IMMX, so the same dollar of news moves IMMX far harder.
- ·GSK pays a dividend and IMMX does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching GSK or IMMX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and IMMX on TheDesperateTrader.
- Is GSK or IMMX the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($96.73B vs $590M). IMMX has been more active on our scanner (153 vs 80 alerts in 30 days). IMMX has the smaller float (83.8M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and IMMX?
- The differences that matter: GSK is roughly 164x the size of the other by market cap ($96.73B vs $590M); they trade at very different share prices ($47.96 vs $6.96); GSK sits at 14% of its 52-week range against 28% for IMMX; only GSK pays a dividend; our scanner flagged GSK 80 times in the last 30 days against 153 for IMMX. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and IMMX is more active right now?
- Right now GSK is at about 0.6x its normal volume and IMMX is at about 1.3x, so IMMX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or IMMX in the stronger trend?
- GSK is below its 50-day average of $49.31 and below its 200-day average of $52.25; IMMX is below its 50-day average of $9.25 and below its 200-day average of $9.64. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or IMMX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GSK and IMMX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.